Cytek Biosciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
solutions company, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Total revenue was $44.9 million, representing a 21% increase over the corresponding period of 2023 Organic revenue was $37.3 million, representing an increase of 11% compared to the first quarter of 2023 First quarter revenue from the product lines acquired from Luminex Corporation (“Luminex”) on February 28, 2023 was $7.6 million Opened a new 50,000-square-foot facility in Wuxi, China to meet growing global demand for cutting-edge cell analysis solutions and to drive operational performance Received China National Medical Products Association (NMPA) approval for single-laser 6-color TBNK panel Registered 18 single-color reagents for IVD use with China NMPA for clinical applications William McCombe appointed Chief Financial Officer “We are encouraged with our positive start to 2024, highlighted by increased organic revenue growth over the fourth quarter a
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences Announces $50 Million Stock Repurchase Program [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences Announces $50 Million Stock Repurchase ProgramGlobeNewswire
- Flow Cytometry Market Poised for $8.3 Billion Boom by 2029 [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewswire
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China [Yahoo! Finance]Yahoo! Finance
CTKB
Earnings
- 5/8/24 - Miss
CTKB
Sec Filings
- 6/7/24 - Form 4
- 6/7/24 - Form 3
- 6/7/24 - Form 4
- CTKB's page on the SEC website